The purpose of this study is to evaluate the safety and effectiveness of the VeraCept Low Dose Intrauterine Copper Contraceptive compared to the standard T shaped copper IUD, the TCu380.

This is a prospective, randomized, subject-blinded, two arm controlled study of the Safety, Feasibility and Effectiveness of the VeraCept low-dose intrauterine copper contraceptive as compared to a concurrently controlled, commercially available standard copper "T" IUD (TCu380).

Inclusion Criteria:

• Adult females ages 18 to 42 (pre-menopausal)
• Have had at least one child (parous) and currently seeking long acting reversible contraception
• Normal uterine cavity as determined by ultrasound
• Willing to sign informed consent
• Able and willing to comply with study assessment schedule

Exclusion Criteria:

• Post menopausal
• Pregnant (at time of enrollment)
• Known anatomical abnormalities of uterus, cervix and/or fallopian tubes
• Diagnosed or in treatment for cancer
• Untreated acute cervicitis
• In treatment for active Pelvic Inflammatory Disease
• Unexplained uterine bleeding or menometrorrhagia
• Known allergy to copper (Wilson's Disease) or imaging contrast media
• Unsuitable for study participation in the opinion of the Principal Investigator